Human Fresh Systemic Lupus Erythematosus Leukopak

Description

Human Fresh Systemic Lupus Erythematosus Leukopak contains leukocytes derived from the peripheral blood of patients clinically diagnosed with Systemic Lupus Erythematosus (SLE), a chronic autoimmune disease. Following apheresis and isolation, the cells are cryopreserved. These leukopaks are enriched in diverse immune cell populations, including autoreactive T cells, B cells, and monocytes that contribute to systemic inflammation and autoantibody production. This product serves as a valuable ex vivo platform for studying the immunological dysfunction in lupus, identifying disease-associated biomarkers, and evaluating the efficacy of novel immunosuppressive or biologic therapies. Repeated freezing and thawing should be avoided. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.